Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2026-03-14 @ 4:04 AM
Study NCT ID:
NCT01682759
Status:
COMPLETED
Last Update Posted:
2018-09-07
First Post:
2012-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-07
First Submit QC Date:
None
Study First Post Date:
2012-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-06
Results First Submit QC Date:
None
Results First Post Date:
2016-02-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-08
Last Update Post Date:
2018-09-07
Last Update Post Date Type:
ACTUAL